Table 3. Immunogenicity Data for Adults.

		Baseline seronegative				All recipients
		Day 0 n = 200, 45 *	Day 15 n = 101, 26 *	Day 29 n = 99, 19 *	Day 57 n = 189, 42 *	Day 0 n = 235, 59 *	Day 15 n = 120, 30 *	Day 29 n = 115, 29 *	Day 57 n = 222, 54 *
GMT
	Vaccine	2.15	2.42	2.57	3.65	3.00	3.46	3.44	4.86
	Placebo	2.09	2.00	2.31	2.48	3.64	2.64	4.96	3.90
Seroconversion rate,%
	Vaccine	NA	3.0	7.1	16.9	NA	2.5	6.1	14.9
	Placebo	NA	0.0	0.0	7.1	NA	0.0	0.0	5.6
GMT ≥32, n (%)
	Vaccine				14 (7.4)				30 (13.5)
	Placebo				1 (2.4)				6 (11.1)
	Rate difference, % , (95% CI)				5.0(–4.9, 10.7)				2.4(–9.3, 10.8)

GMFR = geometric mean fold rise; GMT = geometric mean titer; NA = not applicable.

*All n’s are presented as vaccine, placebo.